Frankfurt
02.10.26 | 08:00
0,049 Euro
+0,41 % +0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.09. | KLARIA PHARMA HOLDING AB: Documents for the extraordinary general meeting will be available no later than September 21, 2026. | 2 | Cision News | ||
| 07.09. | Klaria Pharma Holding AB: Klaria and RTHS enter collaboration agreement for the development of early migraine detection and treatment | 143 | GlobeNewswire (Europe) | Klaria AB and Gothenburg-based RTHS have entered a collaboration agreement that aims to exploit RTHS sensor-based blood dynamics measurements to detect migraine prior to symptoms appearing in patients.... ► Artikel lesen | |
| KLARIA PHARMA Aktie jetzt für 0€ handeln | |||||
| 01.09. | Klaria Pharma Holding AB: Klaria Interim Report Q2 2026 | 138 | GlobeNewswire (Europe) | Summary of interim reportSecond quarter of 2026
The group in total
- Net sales 0.0 MSEK (0.0 MSEK)
- Other income 0.0 MSEK (0.0 MSEK)
- R&D expenses for the quarter amounted to 4.4 MSEK... ► Artikel lesen | |
| 01.09. | Summons to extraordinary general meeting of Klaria Pharma Holding AB (publ) | 1 | Cision News | ||
| 01.09. | Klaria Pharma Holding AB (publ) calls an Extraordinary General Meeting to resolve on a Rights Issue of units and an amendment of the Articles of Association | 1 | Cision News | ||
| 01.09. | Klaria Pharma Holding AB Q2 Loss Narrows | 1 | RTTNews | ||
| 26.08. | KLARIA PHARMA HOLDING AB: Klaria reschedules quarterly report date | 1 | Cision News | ||
| 07.08. | Klaria Pharma Holding AB: Klaria Receives EU Notification of Allowance for Sumatriptan Alginate Film | 684 | GlobeNewswire (Europe) | Klaria has received a Notice of Allowance from the European Patent Office for the second patent in the Sumatriptan Alginate Film (SAF) patent portfolio. The Notice of Allowance indicates that the second... ► Artikel lesen | |
| 26.06. | Klaria Pharma Holding AB: Report from the Annual General Meeting of Klaria Pharma Holding AB (publ) | 446 | GlobeNewswire (Europe) | Today, the Annual General Meeting 2026 of Klaria Pharma Holding AB (publ), reg. no. 556959-2917, was held. Below is a summary of the resolutions adopted by the Annual General Meeting (all in accordance... ► Artikel lesen | |
| 05.06. | KLARIA PHARMA HOLDING AB: Klaria Annual Report 2025 | 1 | Cision News | ||
| 05.06. | Klaria Pharma Holding AB: Klaria receives 25 MSEK in loan financing with the possibility of an additional 15 MSEK | 225 | GlobeNewswire (Europe) | Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that Klaria has entered into an agreement for a bridge loan of 25 MSEK from a Swedish finance company. The agreement also includes... ► Artikel lesen | |
| 29.05. | Klaria Pharma Holding AB: Klaria Interim Report Q1 2026 | 236 | GlobeNewswire (Europe) | Klaria Interim Report Q1 2026 1 January - 31 March
Summary of the interim reportFirst quarter of 2026 The group in total - Net sales 0.1 MSEK (9.0 MSEK)
- Other income 0.0 MSEK (0.0 MSEK)
- R&D... ► Artikel lesen | |
| 28.05. | KLARIA PHARMA HOLDING AB: Klaria adjusts annual report release date | 1 | Cision News | ||
| 25.05. | Klaria Pharma Holding AB: Summons to the Annual General Meeting of Klaria Pharma Holding AB (publ) | 383 | GlobeNewswire (Europe) | With a change from what has been previously announced, the shareholders of Klaria Pharma Holding AB (publ), corporate registration number 556959-2917, are hereby invited to attend the Annual General... ► Artikel lesen | |
| 22.05. | KLARIA PHARMA HOLDING AB: Klaria postpones interim Q1 report | 1 | Cision News | ||
| 21.05. | KLARIA PHARMA HOLDING AB: Klaria postpones publication of the annual report | 2 | Cision News | ||
| 23.04. | Notice of the Annual General Meeting of Klaria Pharma Holding AB (publ) | 1 | Cision News | ||
| 05.04. | KLARIA PHARMA HOLDING AB: Annula Genernal Meeting Date Change: Klaria Pharma Holding (publ) | 2 | Cision News | ||
| 19.03. | Klaria Pharma Holding AB: Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ) | 402 | GlobeNewswire (Europe) | Today, an extraordinary general meeting was held in Klaria Pharma Holding AB (publ), company registration number 556959-2917. Below is a summary of the resolutions adopted by the extra general meeting... ► Artikel lesen | |
| 20.02. | Klaria Pharma Holding AB: Klaria Year-End Report | 797 | GlobeNewswire (Europe) | Klaria Year-End Report Q4 2025
1 January-31 December 2025
SummaryFourth quarter of 2025 The group in total
- Net sales 0.0 MSEK (0.0 MSEK)
- Other income 0.0 MSEK (0.0 MSEK)
- R&D expenses for... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB | 54,72 | +0,09 % | Bristol-Myers Squibb Company: Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa | Originally published by the Bristol Myers Squibb Foundation NORTHAMPTON, MA / ACCESS Newswire / September 28, 2026 / Francis Kwoba is a 68-year-old retired policeman from Bungoma County, Kenya. During... ► Artikel lesen | |
| DERMAPHARM | 37,900 | -1,43 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| INCYTE | 104,90 | +0,62 % | Biotech-Aktien vor dem Datentest: Morgan Stanley setzt auf Biotech-Moonshots: Argenx, Arrowhead, Incyte und Sana vor wichtigen Datentests | Vier Biotech-Unternehmen stehen vor wichtigen klinischen Bewährungsproben. Morgan Stanley sieht bei Argenx, Arrowhead, Incyte und Sana Programme mit hohem wirtschaftlichem Potenzial, deren weiterer... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,070 | +0,66 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| COSMO | 57,00 | 0,00 % | Cosmo Pharmaceuticals N.V.: Largest Real-World Study of the GI Genius Intelligent Endoscopy System Demonstrates Improved Adenoma Detection in Routine Clinical Practice | Randomized empirical evaluation of computer-aided detection, with more than 334,000 colonoscopies performed across U.S. Veterans Health Administration facilities, showed improved adenoma detection ... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 10,250 | +1,49 % | SELLAS Life Sciences Group Inc mit ALARM: Verkaufen Insider bereits? - Handeln Sie, bevor es zu spät ist! | ||
| OPKO HEALTH | 1,440 | +2,86 % | OPKO Health, Inc.: OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests | MIAMI, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the expansion of its financing relationship with HealthCare Royalty, a business of KKR (HCRx), through... ► Artikel lesen | |
| OXFORD BIOMEDICA | 5,850 | -2,50 % | Oxford Biomedica PLC - Total Voting Rights | ||
| SUMITOMO PHARMA | 9,145 | +0,10 % | Sumitomo Pharma, Novo Nordisk Win Japan Nod For Wegovy In MASH | TOKYO (dpa-AFX) - Sumitomo Pharma Co., Ltd. (4506.T) announced on Friday that Japan has cleared Wegovy Subcutaneous Injection, which it co-promotes with Novo Nordisk B A/S (NVO), to treat metabolic... ► Artikel lesen | |
| CITIUS PHARMACEUTICALS | 0,538 | +0,02 % | Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update | $7.1 Million in revenue for the first nine months of fiscal 2026 from commercial sales of LYMPHIR ®
$17 million in cash and cash equivalents as of June 30, 2026
Expanded... ► Artikel lesen | |
| VETOQUINOL | 73,30 | 0,00 % | Vetoquinol: 2026 Half Year Results | Sales: €259 million (+3.4% at constant exchange rates and +0.7% on a reported basis)
Essential Products sales: €169 million (+3.7% at constant exchange rates and +2.2% on a reported basis)
EBIT... ► Artikel lesen | |
| ASTRID INTELLIGENCE | 0,002 | 0,00 % | Astrid Intelligence - Green Compute Partnership and Operational Update | ||
| BIOHARVEST SCIENCES | 1,150 | -8,00 % | BioHarvest Sciences Inc.: BioHarvest Sciences Announces Share Repurchase Program | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical... ► Artikel lesen | |
| OCUMENSION THERAPEUTICS | 0,535 | -1,83 % | NICOX SA: Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension | Press Release Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension
Ocumension has submitted the New Drug Application (NDA) to the Chinese National Medical Products Administration... ► Artikel lesen | |
| BAYER | 45,580 | +0,40 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln |
KLARIA PHARMA HOLDING AB gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,049 Euro und damit +0,41 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KLARIA PHARMA HOLDING AB finden Sie auf Wallstreet Online.